99 days ago
I do not know but I speculate. Optibiotix (OPTI) will publish its results for the year to December 31 at some point in June. History suggests that it will be at the end of the month.
102 days ago
A TR1 is just up, the purchaser of the 8.9 million Skinbiotherapeutics (SBTX) dumped by Police Time Wastin’ Steve O’Hara’s Optibiotix, is, as I predicted, that Mark Dixon fellow. He paid 9p for the shares so is averaging down/catching a falling knife.
151 days ago
I was a constant bear of ITM Power (ITM) although comrade Malcolm Stacey used to worship at the alter of man made global warming and so was a fan. At one stage at peak green bubble its shares were 682p – a market cap of £3.5 billion. Today, with Cooley having left the building four years ago, they are 62p – just 12p above the IPO price back in 2004. Old comrade Stacey would have done better putting his cash in the Nationwide Building Society.
161 days ago
It was not a bad season for West Ham but that is not what we were discussing it was the parallels with 2026, Blue Owl, Bear Stearns, oil, base rates and gold. Them I look at the BSF Enterprise (BSFA) scandal, Skinbiotherapeutics (SBTX) and more Mark Dixon share buying and also is it THE Colette Quinn who wants to silence me over Valareum (VLRM)
189 days ago
We still have no idea why Stuart Ashman "resigned" fromSkinbiotherapeutics (SBTX) on Thursday night. What we do know is that he had already been suspended by the board as part of an investigation into his conduct. The question AIM Regulation should be asking is when the investigation/suspension started and has the company breached AIM Rule 10. I have written to my pals the Oxymorons at AIM Regulation
224 days ago
As discussed in bearcast earlier, shares in Skinbiotherapeutics (SBTX) may or may not be cheap or expensive. What I neglected to say is that some are arguing that the continued buying by Mark Dixon, he now owns 16.2%, shows that they are cheap: he would not buy so many shares if he did not know something. Hmmmm.
